Form 4: GeneDx Holdings Corp. CFO Kevin Feeley Reports Stock Unit Activity

Sentiment:

SEC Form 4 Filing


Kevin Feeley, CFO of GeneDx Holdings Corp., reports the acquisition of 2,462 Class A Common Stock units through the vesting of restricted stock units on March 9, 2024.

Summary

  • On March 9, 2024, Kevin Feeley, the Chief Financial Officer of GeneDx Holdings Corp., acquired 2,462 shares of Class A Common Stock.
  • This acquisition resulted from the vesting of restricted stock units.
  • Following the transaction, Feeley directly owns 25,914 shares of Class A Common Stock and 27,083 restricted stock units.
  • The restricted stock units vest in quarterly installments over a 4-year period starting March 9, 2023.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reflects a standard executive compensation transaction. It's neither particularly positive nor negative.

Positives

  • The vesting of restricted stock units indicates a continued alignment of the CFO's interests with the company's performance.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.

Stakeholder Impact

  • The transaction has a minor positive impact on shareholders as it aligns management's interests with the company's performance.

Key Dates

DateDescription
03/09/2023Commencement date for quarterly vesting of restricted stock units over a 4-year period.
03/09/2024Date of transaction: Acquisition of 2,462 shares of Class A Common Stock through vesting of restricted stock units.
03/12/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.